A Clinical Study of Purinostat Mesylate for Injection in Patients With Advanced Solid Tumors

Clinical trial NCT06431243 · RECRUITING

Trial details

NCT number: NCT06431243
Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-05-08
Primary completion: 2026-05-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.